コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 t protein kinase, (8R,9S, 11S)-(-)-9-methoxy-carbamyl-8-methyl-2,3,9,10-tetrahydro-8, 11-epoxy-1H,8H,
2 sed PKG inhibitors (8R,9S,11S)-(-)-9-methoxy-carbamyl-8-methyl-2,3,9,10-tetrahydro-8,11-epoxy -1H,8H,
4 dimetal TnDhp in complexes with hydantoin, N-carbamyl-beta-alanine, and N-carbamyl-beta-amino isobuty
5 th hydantoin, N-carbamyl-beta-alanine, and N-carbamyl-beta-amino isobutyrate as well as apo-TnDhp in
9 of inhibitor cleavage to generate a covalent carbamyl-enzyme intermediate rather than a tetrahedral c
10 tion of a hydrazide-containing product and a carbamyl-enzyme intermediate that is sufficiently stable
11 activity is observed when the length of the carbamyl function is n = 6 and n = 7 for porcine and rat
13 loyl) GTP (mantGTP), 2'(3')-O-[(2-aminoethyl)carbamyl] GTP (edGTP), and adducts of fluorescein 5-isot
14 In the pyrimidine biosynthetic pathway, N-carbamyl-L-aspartate (CA-asp) is converted to L-dihydroo
15 ia coli ligated to products (phosphate and N-carbamyl-l-aspartate) has been determined at 2.37 A reso
17 onaemia will allow specific treatment with N-carbamyl-l-glutamate and prevent neurological sequelae.
19 d by avibactam via formation of a reversible carbamyl linkage of the inhibitor with the catalytic ser
20 s PUs featuring fully substituted (tertiary) carbamyl nitrogen atoms, a structural motif that is almo
24 nonhydrolyzable PAF receptor agonist methyl carbamyl PAF (mc-PAF) on the unidirectional in vitro mig
25 uterine or intraperitoneal administration of carbamyl PAF activates inflammation in gestational tissu
27 pecific (A23187) and specific (endothelin-1, carbamyl-PAF) stimulation, suggesting a role for this in
30 distance is 45.2 A) when ATCase is bound to carbamyl phosphate (CP) and to L-alanosine (an analogue
32 roduction of L-citrulline and phosphate from carbamyl phosphate and L-ornithine in L-arginine biosynt
33 f this novel transcarbamylase complexed with carbamyl phosphate and N-succinyl-L-norvaline, as well a
34 e of Escherichia coli ATCase maintained with carbamyl phosphate and succinate, phosphonoacetamide and
36 to the synthetase domain (CPS domain), where carbamyl phosphate formation is catalyzed in three conse
38 sfers ammonia to the synthetase domain where carbamyl phosphate is formed in a three-step reaction se
39 other ligands (N-phosphonacetyl-L-aspartate, carbamyl phosphate plus malonate, phosphonoacetamide plu
40 nthesis reaction of biotin carboxylase where carbamyl phosphate reacted with ADP by holoBCCP87 was 5-
41 minimal medium and can suppress mutations in carbamyl phosphate synthase-aspartate carbamyl transfera
42 omains of CAD stimulates glutamine-dependent carbamyl phosphate synthesis and abolishes the ammonia-d
43 e enzyme can also catalyze ammonia-dependent carbamyl phosphate synthesis if provided with exogenous
44 utant not only catalyzed glutamine-dependent carbamyl phosphate synthesis, but was activated 10-fold
47 e 150-kDa band revealed sequence identity to carbamyl phosphate synthetase I (CPS I) and a high degre
49 alogue of molecular changes in patients with carbamyl phosphate synthetase I (CPSI) deficiency to dev
53 lated trifunctional enzyme known as CAD (for carbamyl phosphate synthetase, aspartate transcarbamylas
54 d-Ala d-Ala ligase, glutathione synthetase, carbamyl phosphate synthetase, N(5)-carboxyaminoimidazol
56 The K(m) values for N-acetylornithine and carbamyl phosphate were 1.05 mM and 0.01 mM, respectivel
57 lyzes the conversion of metabolic ammonia to carbamyl phosphate, the rate-limiting step in urea biosy
62 nzymes, ornithine transcarbamylase (OTC) and carbamyl-phosphate synthase (CPS), as well as dibasic am
64 glutaminase domain (GLN domain) of mammalian carbamyl-phosphate synthetase II (CPSase II) catalyzes g
65 midotransferase domain (GLNase) of mammalian carbamyl-phosphate synthetase II hydrolyzes glutamine an
66 s was deleted and the sequences encoding the carbamyl-phosphate synthetase subunits were fused in fra
68 ons in carbamyl phosphate synthase-aspartate carbamyl transferase within the pyrimidine pathway; the